Morgan Stanley lowered the firm’s price target on Accelerant (ARX) to $18 from $26 and keeps an Equal Weight rating on the shares. The firm said that, broadly speaking, commercial property and casualty continues to face growth headwinds from the commercial property pricing slowdown in both primary and reinsurance sub-sectors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARX:
- Accelerant price target lowered to $18 from $25 at Piper Sandler
- Accelerant upgraded to Buy from Neutral at Goldman Sachs
- Mixed Sentiment on Accelerant Holdings: Hold Rating Amid Growth and Structural Challenges
- Accelerant price target lowered to $21 from $33 at Raymond James
- Accelerant partners with AF Specialty to boost risk exchange capacity